单唾液酸神经节苷脂GM2结构式
|
常用名 | 单唾液酸神经节苷脂GM2 | 英文名 | Ganglioside GM2 Mixture (bovine brain) (ammonium salt) |
|---|---|---|---|---|
| CAS号 | 19600-01-2 | 分子量 | 1384.682 | |
| 密度 | 1.3±0.1 g/cm3 | 沸点 | 1417.9±65.0 °C at 760 mmHg | |
| 分子式 | C67H121N3O26 | 熔点 | N/A | |
| MSDS | 美版 | 闪点 | 811.3±34.3 °C |
| 中文名 | 神经节苷酯GM2 |
|---|---|
| 英文名 | ganglioside GM2 |
| 英文别名 | 更多 |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 1417.9±65.0 °C at 760 mmHg |
| 分子式 | C67H121N3O26 |
| 分子量 | 1384.682 |
| 闪点 | 811.3±34.3 °C |
| 精确质量 | 1383.823853 |
| LogP | 10.77 |
| 蒸汽压 | 0.0±0.6 mmHg at 25°C |
| 折射率 | 1.577 |
| 储存条件 | -20°C |
| 计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:17 3.氢键受体数量:26 4.可旋转化学键数量:50 5.互变异构体数量:8 6.拓扑分子极性表面积461 7.重原子数量:97 8.表面电荷:0 9.复杂度:2200 10.同位素原子数量:0 11.确定原子立构中心数量:23 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:1 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
| 更多 | 1. 性状:不确定 2. 密度(g/mL,25/4℃):不确定 3. 相对蒸汽密度(g/mL,空气=1):不确定 4. 熔点(ºC):不确定 5. 沸点(ºC,常压):不确定 6. 沸点(ºC, 5.2kPa):不确定 7. 折射率:不确定 8. 闪点(ºC):不确定 9. 比旋光度(º):不确定 10. 自燃点或引燃温度(ºC):不确定 11. 蒸气压(kPa,25ºC):不确定 12. 饱和蒸气压(kPa,60ºC):不确定 13. 燃烧热(KJ/mol):不确定 14. 临界温度(ºC):不确定 15. 临界压力(KPa):不确定 16. 油水(辛醇/水)分配系数的对数值:不确定 17. 爆炸上限(%,V/V):不确定 18. 爆炸下限(%,V/V):不确定 19. 溶解性:三氯甲烷/甲醇(9:1): 10 mg/mL,微黄 |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危险品运输编码 | NONH for all modes of transport |
|
Altered levels of α-synuclein and sphingolipids in Batten disease lymphoblast cells.
Gene 539(2) , 181-5, (2014) Batten disease (juvenile neuronal ceroid lipofuscinosis) is a neurodegenerative disorder characterized by blindness, seizures, cognitive decline, and early death due to the inherited mutation of the C... |
|
|
Ganglioside-embedding small bicelles for probing membrane-landing processes of intrinsically disordered proteins.
Chem. Commun. (Camb.) 49(12) , 1235-7, (2013) We successfully displayed a series of gangliosides on small bicelles with a uniform confined size, offering nanoscale standardized membrane mimics for spectroscopic characterization of weak encounter ... |
|
|
Use of carbohydrate-conjugated nanoparticles for an integrated approach to functional imaging of glycans and understanding of their molecular mechanisms.
Curr. Pharm. Biotechnol. 13(14) , 2612-6, (2012) Functional analysis of carbohydrates is needed to understand the initial interface between membranes and the outer world. For this analysis we need individual protocols such as a method to modify the ... |
| (2R,3S,4E)-3-Hydroxy-2-(stearoylamino)-4-octadecen-1-yl 2-acetamido-2-deoxy-β-L-galactopyranosyl-(1->4)-[(6S)-5-acetamido-3,5-dideoxy-6-[(1S,2S)-1,2,3-trihydroxypropyl]-β-D-threo-hex-2-ulopyrano nosyl-(2->3)]-β-L-galactopyranosyl-(1->4)-β-L-glucopyranoside |
| MFCD00131137 |
| Octadecanamide, N-[(1R,2S,3E)-1-[[[O-2-(acetylamino)-2-deoxy-β-L-galactopyranosyl-(1->4)-O-[5-(acetylamino)-3,5-dideoxy-L-glycero-α-L-galacto-2-nonulopyranonosyl-(2->;3)]-O-β-L-galactopyranos yl-(1->4)-β-L-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]- |